Synergy Pharmaceuticals Inc. (SGYP), Monday reported fourth-quarter net loss of $12.0 million or $0.18 per share, wider than $5.6 million or $0.12 per share last year.
Analysts polled by Thomson Reuters estimated loss of $0.16 per share for the quarter. Analysts' estimates typically exclude one-time items.
Research and development costs for the quarter increased to $9.1 million from $5.7 million last year. General and administrative expenses rose to $2.4 million from $2.2 million last year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.